Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma. | Endocrine | 2022 | 34536194 | PubTator, text mining | PubMed |
| A long noncoding RNA-microRNA expression signature predicts metastatic signature in pheochromocytomas and paragangliomas. | Endocrine | 2022 | 34536193 | PubTator, text mining | PubMed |
| International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma. | J Med Genet | 2022 | 34452955 | PubTator, text mining | PubMed |
| Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA). | AJR Am J Roentgenol | 2022 | 34431366 | PubTator, text mining | PubMed |
| Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. | Clin Cancer Res | 2022 | 34426440 | PubTator, text mining | PubMed |
| Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience. | J Endocrinol Invest | 2022 | 34227051 | PubTator, text mining | PubMed |
| Personalized Management of Pheochromocytoma and Paraganglioma. | Endocr Rev | 2022 | 34147030 | PubTator, text mining | PubMed |
| Metabolic reprogramming and epigenetic modifications on the path to cancer. | Protein Cell | 2022 | 34050894 | PubTator, text mining | PubMed |
| Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma. | J Med Genet | 2022 | 33219105 | PubTator, text mining | PubMed |
| Clinical and histopathological principles for the diagnosis of a recurrent paraganglioma of the jugular foramen initially diagnosed as a middle ear adenoma: illustrative case. | J Neurosurg Case Lessons | 2021 | 36131578 | PubTator, text mining | PubMed |
| The Utility of 68Ga-DOTATATE PET/CT in Localizing Primary/Metastatic Pheochromocytoma and Paraganglioma: Asian Indian Experience. | Indian J Endocrinol Metab | 2021 | 35300451 | PubTator, text mining | PubMed |
| [Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma]. | Probl Endokrinol (Mosk) | 2021 | 35262293 | PubTator, text mining | PubMed |
| Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion. | Discov Oncol | 2021 | 35201450 | PubTator, text mining | PubMed |
| Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death. | Front Oncol | 2021 | 35127502 | PubTator, text mining | PubMed |
| Succinate dehydrogenase-deficient gastrointestinal stromal tumor: from diagnostic dilemma to novel personalised therapy in 2 case reports. | Transl Cancer Res | 2021 | 35116662 | PubTator, text mining | PubMed |
| Bilateral Paragangliomas in the Setting of Autonomic Dysfunction: A Case Report. | Case Rep Neurol | 2021 | 35111028 | PubTator, text mining | PubMed |
| Successful Response to Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy in a Patient with Metastatic Carotid Body Paraganglioma. | Case Rep Oncol | 2021 | 35111016 | PubTator, text mining | PubMed |
| Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives. | Case Rep Oncol | 2021 | 35082626 | PubTator, text mining | PubMed |
| Diagnosis and Outcome of Cardiac Paragangliomas: A Retrospective Observational Cohort Study in China. | Front Cardiovasc Med | 2021 | 35071353 | PubTator, text mining | PubMed |
| SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor. | Front Oncol | 2021 | 35059314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=35